STOCK TITAN

LeMaitre to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

LeMaitre Vascular announced that CFO JJ Pellegrino will present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 16, 2022, at 10:30 AM ET.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

Rhea-AI Summary

LeMaitre Vascular announced that CFO JJ Pellegrino will present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 16, 2022, at 10:30 AM ET. The company specializes in devices and services for treating peripheral vascular disease, impacting over 200 million people globally. LeMaitre develops and markets both disposable and implantable vascular devices tailored for vascular surgeons. More information is available at www.lemaitre.com.

Loading...
Loading translation...
Argus Session date unavailable
-1.29% session move Open Argus
Details

News Market Reaction – LMAT

The recorded move for LMAT in the trading session of this news was -1.29%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

BURLINGTON, Mass., Feb. 09, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Wednesday, February 16, 2022, at 10:30 AM ET.

LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is LeMaitre Vascular's presentation date and time at the BTIG Conference?

LeMaitre Vascular's CFO JJ Pellegrino will present on February 16, 2022, at 10:30 AM ET.

What is the focus of LeMaitre Vascular's business?

LeMaitre Vascular provides devices and services for the treatment of peripheral vascular disease.

How many people are affected by peripheral vascular disease globally?

Peripheral vascular disease affects more than 200 million people worldwide.

What types of products does LeMaitre Vascular offer?

LeMaitre Vascular develops disposable and implantable vascular devices.

Where can I find more information about LeMaitre Vascular?

More information can be found at www.lemaitre.com.

Keep reading